Artisan Partners’s Nektar Therapeutics NKTR Stock Holding History

Artisan Partners’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-3,887	Closed	-$1.4M	–	281
2017 Q3	$1.4M	Buy	+3,887	New	+$1.22M	﹤0.01%	258
2016 Q3	–	Sell	-66,855	Closed	-$14.3M	–	279
2016 Q2	$14.3M	Buy	66,855 +10,581	+19%	+$2.37M	0.03%	229
2016 Q1	$11.6M	Buy	56,274 +8,337	+17%	+$1.6M	0.02%	247
2015 Q4	$12.1M	Buy	47,937 +5,670	+13%	+$1.17M	0.02%	255
2015 Q3	$6.95M	Buy	42,267 +1,370	+3%	+$242K	0.01%	315
2015 Q2	$7.67M	Buy	40,897 +372	+0.9%	+$64K	0.01%	318
2015 Q1	$6.69M	Buy	+40,525	New	+$8.33M	0.01%	334

Other funds holding NKTR

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Artisan Partners's NKTR Position: Q4 2017 in Review

Artisan Partners sold out of Nektar Therapeutics (NKTR) in Q4 2017, closing a stake of 3,887 shares — an estimated $1.4M sold.

Artisan Partners first reported a position in NKTR in Q1 2015 and held it in 7 quarters. The position peaked at $14.3M in Q2 2016. 265 funds tracked by Wall St. Rank hold NKTR as of Q4 2017.

Artisan Partners reported no remaining Nektar Therapeutics position as of Q4 2017 after selling out during the quarter.
Artisan Partners sold 3,887 Nektar Therapeutics shares in Q4 2017, an estimated $1.4M.
Artisan Partners first reported a position in Nektar Therapeutics in Q1 2015 and held it in 7 quarters.
Artisan Partners's Nektar Therapeutics position peaked at $14.3M in Q2 2016.
265 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2017.

Based on Artisan Partners's 13F filing for Q4 2017, filed 12 Feb 2018.